Latest Close
$0.52
News
ACTU
Actuate Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to ACTU.
1y Change
-$6.73 (-92.88%)
Market Cap
$12,396,131.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in Schizophrenia
Zacks • Oct 12, 2026
Read articleAbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
Zacks • Oct 8, 2026
Read articleTop Premarket Decliners
MT Newswires • Oct 7, 2026
Read articleActuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire • Sep 9, 2026
Read articleActuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib
GlobeNewswire • Sep 9, 2026
Read articleAll You Need to Know About Actuate Therapeutics, Inc. (ACTU) Rating Upgrade to Buy
Zacks • Sep 2, 2026
Read article